NEOPRESSION 4 MG 20 F.C.TABS

About Brexpiprazole Brexpiprazole is a novel D2 dopamine and serotonin 1A partial agonist called serotonin-dopamine activity modulator (SDAM) and a potent antagonist of serotonin 2A receptors noradrenergic alpha 1B and 2C receptors. Mechanism of Action of Brexpiprazole The mechanism of action of brexpiprazole in the treatment of major depressive disorder or schizophrenia is unknown. However the efficacy of brexpiprazole may be mediated through a combination of partial agonist activity at serotonin 5-HT1A and dopamine D2 receptors and antagonist activity at serotonin 5-HT2A receptors. Indications for Brexpiprazole 1. Adjunctive treatment of major depressive disorder (MDD) 2. Treatment of schizophrenia